SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-056467
Filing Date
2020-11-02
Accepted
2020-11-02 20:00:44
Documents
2
Period of Report
2020-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1669
2 POA DOCUMENT poa.txt EX-24.3_943110 3532
  Complete submission text file 0001209191-20-056467.txt   6699
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Issuer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address
Ng-Cashin Judith (Reporting) CIK: 0001830357 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36306 | Film No.: 201281664